Charles River Laboratories International (CRL) Depreciation and Depletion: 2011-2025
Historic Depreciation and Depletion for Charles River Laboratories International (CRL) over the last 15 years, with Sep 2025 value amounting to $44.8 million.
- Charles River Laboratories International's Depreciation and Depletion fell 7.63% to $44.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $180.9 million, marking a year-over-year decrease of 3.93%. This contributed to the annual value of $190.2 million for FY2024, which is 7.64% up from last year.
- Latest data reveals that Charles River Laboratories International reported Depreciation and Depletion of $44.8 million as of Q3 2025, which was up 1.13% from $44.3 million recorded in Q2 2025.
- Charles River Laboratories International's 5-year Depreciation and Depletion high stood at $155.6 million for Q4 2022, and its period low was $559,000 during Q1 2022.
- Over the past 3 years, Charles River Laboratories International's median Depreciation and Depletion value was $44.8 million (recorded in 2025), while the average stood at $45.4 million.
- Over the last 5 years, Charles River Laboratories International's Depreciation and Depletion had its largest YoY gain of 7,878.53% in 2023, and its largest YoY loss of 70.12% in 2023.
- Quarterly analysis of 5 years shows Charles River Laboratories International's Depreciation and Depletion stood at $138.6 million in 2021, then climbed by 12.28% to $155.6 million in 2022, then crashed by 70.12% to $46.5 million in 2023, then climbed by 4.09% to $48.4 million in 2024, then decreased by 7.63% to $44.8 million in 2025.
- Its Depreciation and Depletion was $44.8 million in Q3 2025, compared to $44.3 million in Q2 2025 and $43.4 million in Q1 2025.